Sapanisertib (MLN0128) - mTOR inhibitor CAS:1224844-38-5
- HHD
- Wuhan
- 100 piece/month
New arrival!
Good quality!
IN STOCK
Product Name | Sapanisertib (MLN0128) |
CAS No. | 1224844-38-5 |
Appearance | Powder |
Purity | 99% |
MF | C15H15N7O |
Shelf Life | 2 Years |
| Grade | Enterprise standard |
| Solubility | Soluble in DMSO (up to 25 mg/ml) |
| Usage | For research use only |
Sapanisertib (MLN0128, INK128, TAK-228), a dual mTORC1/2 kinase inhibitor, is undergoing further clinical trials after showing a suitable safety profile and preliminary antitumor activity in combination with paclitaxel, with and without trastuzumab, in a range of advanced solid tumor types
Do we have the test reports for our products provided by the independent third party?
Every batch of our product was tested by authorized independent third party, Analysis testing center, Shanghai branch, Chinese Academy of Science. We send goods to customers with test report and COA. Our products were also tested by American Analytical Chemistry Laboratories and Chromadex too....more
Every batch of our product was tested by authorized independent third party, Analysis testing center, Shanghai branch, Chinese Academy of Science. We send goods to customers with test report and COA. Our products were also tested by American Analytical Chemistry Laboratories and Chromadex too....more
![ADQ//3-Acetyl-5,8-dichloro-2-[(2,4-dichlorophenyl)amino]-4(1H)-quinolinone CAS:1151813-62-5](https://img.waimaoniu.net/1363/1363-202212061656158414.jpg)
Product Tag:
